Joseph DeSimone, PhD, the Chancellor’s Eminent Professor of Chemistry and a joint Professor in the Department of Pharmacology, has been elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine. This election represents the third time Desimone has been elected to a U.S. National Academy.
Roth’s research to create innovative tools for neuroscientists and discover potential targets for therapeutics has earned him one of the highest honors in the field of medicine.
Led by Bryan L. Roth, MD, PhD, three UNC labs will develop the next generation neuroscience tool-kit to accelerate novel treatments for neuropsychiatric and a host of other diseases. ~by Mark Derewicz
Bryan Roth and Gary Johnson Awarded NIH Grants From the NIH Illuminating the Druggable Genome Initiative
Drs. Bryan Roth and Gary Johnson receive 2 of 9 grants awarded by the NIH Illuminating the Druggable Genome Initiative which is supporting research to study 4 of the most commonly drug-targeted protein families
Zefeng Wang's paper published in Cancer Cell this week shows that the splicing factor RBM4 suppresses proliferation and migration of various cancer cells by specifically controlling cancer-related splicing.
Michael Miley, PhD, and Ashutosh Tripathy, PhD, are the new co-directors for the UNC Center for Structural Biology (CSB). CSB has also launched a brand new website.
Dr. Terry Kenakin to Receive the 2014 Gaddum Memorial Award from the British Pharmacological Society.
Press release by Mark Derewicz for UNC Hahn Lab paper published online in Nature Chemical Biology March 9, 2014.
New targeted therapies for pain, Parkinson's disease, and depression carry the promise of greater benefit for patients without serious side effects.
In a paper published in Nature Neuroscience on November 10, Juan Song discovers how baby neurons stay alive, a key finding for understanding neurodegenerative diseases, such as Alzheimer’s.